Mahboubeh Mansouri

Mahboubeh Mansouri


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2014 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
AAAsghar Aghamohammadi
Asghar Aghamohammadi
PMPayam Mohammadinejad
Payam Mohammadinejad
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
BMBabak Mirminachi
Babak Mirminachi
MMMasoud Movahedi
Masoud Movahedi
NRNima Rezaei
Nima Rezaei

1 April 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
JCJanet Chou
Janet Chou
WBWayne Bainter
Wayne Bainter
CPCraig D. Platt
Craig D. Platt
MTMahmood Tavassoli
Mahmood Tavassoli
AAAsghar Aghamohammadi
Asghar Aghamohammadi

1 January 2006 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
AAAsghar Aghamohammadi
Asghar Aghamohammadi
NPNima Parvaneh
Nima Parvaneh
FTFarrokh Tirgari
Farrokh Tirgari
FMFatemeh Mahjoob
Fatemeh Mahjoob
MMMasoud Movahedi
Masoud Movahedi
DWDavid Webster
David Webster
Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency characterized by reduced levels of all major immunoglobuline classes and recurrent c infections. The risk of non-Hodgkin's lymphoma (NHL) among patients with CVID was found to be increased in different studies. Mucosa-associated lymphoid tissue (MALT) lymphomas are a recently recognized sub-set of low-grade B-cell NHL composed of marginal zone-related cells. MALT lymphomas appear in the lymphoid tissues as a result of chronic inflammatory or autoimmune stimulation. This study briefly reviews previously published cases and reports a patient suffering from CVID with a history of chronic diarrhea and recurrent sinopulmonary infections. Despite treatment with intravenous immunoglobulin, chronic cough and wheezing progressed. Open lung biopsy showed a MALT lymphoma. Although a rare complication, pulmonary low grade B-cell lymphoma is a diagnosis that must be kept in mind in CVID patients with chronic pulmonary symptoms unresponsive to conventional therapies.

25 April 2005 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
ZPZahra Pourpak
Zahra Pourpak
MMMehrnaz Mesdaghi
Mehrnaz Mesdaghi
MMMahboubeh Mansouri
Mahboubeh Mansouri
AKAnoushiravan Kazemnejad
Anoushiravan Kazemnejad
STShahram Beiraghi Toosi
Shahram Beiraghi Toosi
AFAbolhasan Farhoudi
Abolhasan Farhoudi

25 August 2016 in International Archives of Allergy and Immunology
Verified
Journal Article
Open access
PDF file
ZKZahra Karami
Zahra Karami
MMMehrnaz Mesdaghi
Mehrnaz Mesdaghi
PKParvaneh Karimzadeh
Parvaneh Karimzadeh
MMMahboubeh Mansouri
Mahboubeh Mansouri
MTMohammad Mehdi Taghdiri
Mohammad Mehdi Taghdiri
ZCZahra Chavoshzadeh
Zahra Chavoshzadeh
Background/Aim: Administration of the anticonvulsant drugs phenobarbital, phenytoin, carbamazepine and lamotrigine can be associated with severe hypersensitivity reactions. The lymphocyte transformation test (LTT) is a method to determine which drug has caused the hypersensitivity reaction. This study was done to evaluate the results of LTT in patients with delayed hypersensitivity reactions following the administration of anticonvulsants. Methods: Twenty-four patients with hypersensitivity reactions, e.g. drug-induced hypersensitivity syndrome/drug rash and eosinophilia with systemic symptoms (DIHS/DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN), following the administration of anticonvulsant drugs, and 24 patients who had used anticonvulsant drugs but did not have hypersensitivity reactions (the control group) were included in this study. Peripheral blood mononuclear cells were isolated. The cells were stimulated with the drugs, phytohemagglutinin as a mitogen and Candida as an antigen (positive controls). Lymphocyte proliferation was measured using the BrdU proliferation assay kit (Roche, Germany). The stimulation index was calculated as the mean ratio of the OD of stimulated cells divided by the OD of unstimulated cells. The results in the case and control groups were compared. Results: Of 24 patients in the test group, 14 (58.3%) had positive LTT results and 10 (41.7%) had negative results. Among patients in the control group, 1 (4.2%) had a positive LTT result and 23 (95.8%) had negative results. Among the patients who had received carbamazepine and phenytoin, there was a significant difference between the results of LTT in the case and control groups (p = 0.002 and p = 0.028, respectively). Although patients receiving lamotrigine and phenobarbital had more positive LTT results in the case group than in the control group, these differences were not statistically significant. The sensitivity, specificity, positive predictive value and negative predictive value of LTT were 58.4, 95.8, 93.3 and 69.9%, respectively. Conclusions: Considering the significant difference in LTT results between the case and control groups in patients receiving carbamazepine and phenytoin, and not observing such a difference in patients receiving phenobarbital and lamotrigine, LTT results are more valuable for the diagnosis of hypersensitivity reactions following the administration of carbamazepine and phenytoin. The LTT has good specificity but low sensitivity for the diagnosis of drug hypersensitivity reactions.

1 February 2004 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
ZPZahra Pourpak
Zahra Pourpak
MMMahboubeh Mansouri
Mahboubeh Mansouri
MMMehrnaz Mesdaghi
Mehrnaz Mesdaghi
AKAnoushiravan Kazemnejad
Anoushiravan Kazemnejad
AFAbolhasan Farhoudi
Abolhasan Farhoudi
Background: Food allergy affects 6–8% of infants and wheat allergy is one of the common food allergies among children. The clinical and laboratory manifestations of wheat allergy were evaluated in this study. Methods: Thirty-two children (≤12 years old) with suspected wheat allergy were evaluated for wheat allergy. The patients underwent wheat skin prick test (SPT), measurement of wheat-specific IgE and wheat challenge test. The patients with a convincing history of anaphylaxis following ingestion of wheat or with a positive challenge test, and those with a history of immediate hypersensitivity reaction following ingestion of wheat in addition to a positive wheat SPT and/or positive wheat-specific IgE were considered wheat allergic. Then, the laboratory and clinical manifestations of their disease were studied. Results: Among patients with suspected wheat allergy, 24 patients with definite wheat allergy were identified. Anaphylaxis was a dominant clinical feature, accounting for 54.1% of acute symptoms. Chronic allergy symptoms like asthma and eczema were noted in 50% of the patients. Wheat-specific IgE was higher in patients with anaphylaxis (p < 0.02) and the risk of anaphylaxis was 14.4 times more in patients with wheat-specific IgE equal to or more than 3+. Conclusions: Anaphylaxis had occurred in a remarkable number of patients repeatedly, which demonstrates the severity of the reactions, poor knowledge of the disease and probable existence of more patients with mild reactions. Regarding the higher level of wheat-specific IgE in patients with anaphylaxis, wheat-specific IgE could be used to predict the severity of symptoms.